Inappropriate conclusions from the use of botulinum toxin for the treatment of spasticity.
Zakine
Benjamin
B
Maisonobe
Pascal
P
Pickett
Andy M
AM
D019274:Botulinum Toxins, Type A / Q000009:adverse effects*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000139:chemically induced*; D006801:Humans; D009128:Muscle Spasticity / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000009:adverse effects*; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A